HORNIG GEORGE R - 03 Jan 2022 Form 4 Insider Report for Vaxxinity, Inc.

Role
Director
Signature
Renr Paula Molina, attorney-in-fact for Jason Pesile
Issuer symbol
VAXX on OTC
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 18:41:38 UTC
Previous filing
02 Aug 2021
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAXX Stock Option (right to buy) Award $0 +67,953 $0.000000 67,953 03 Jan 2022 Class A common stock 67,953 $5.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are subject to a four-year time-vesting schedule, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal installments each month during the remainder of the vesting period.